Co-Scientist is a new initiative merging MIT and Boston Children’s Hospital expertise. It will focus on RNA-based therapeutic approaches to combat Amyotrophic Lateral Sclerosis (ALS), aiming to accelerate discovery in neurodegenerative disease research. This collaboration bridges computational biology and clinical application, seeking novel treatments.
Opening Kapyn…